ALCOHOL
(ETHANOL)
Drug class: Retention Time: Alcohol Equivalencies: |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Blood Alcohol Levels and Impact on Behavior: (Approximation Only) | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Relationship of Blood Alcohol Level to Urine Levels Since ethanol levels are being determined on random urine
samples there is no way to determine the stage of metabolism,
i.e. absorption or elimination. For this reason an average
conversion factor of 1.3 is used to convert the urine
ethanol level to a corresponding blood level (Estimation
only). EIA is optimized to detect ethanol; however other alcohols or volatiles (isopropanol, methanol, acetone, etc.) at high levels may cross-react. Gas Chromatography head space (GC/HS) will specifically identify and quantitate ethanol. In addition a urine sample containing both yeast (contamination or infection) and glucose (diabetes) will result in fermentation within the bladder or sample bottle thus producing ethanol. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Forensic
Laboratories Ethanol Cutoff Level for urine samples =
.05 g/100mL. Only levels greater than this value will
be reported detected. |
||||||||||||||||||||||||||||||||||||||||||||||||||
AMPHETAMINES
Drug class: Retention
Time: Alcohol Equivalencies: Retention:
(Detection) Times: |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Compounds which are metabolized to MA & A | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Compounds which are metabolized to MA & A | ||||||||||||||||||||||||||||||||||||||||||||||||||
NOTES:
|
||||||||||||||||||||||||||||||||||||||||||||||||||
BARBITURATES
Drug
class: DEA Classification: Retention Times: |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| * Reported as Barbiturate positive - Not Phenobarbital |
||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Notes:
|
||||||||||||||||||||||||||||||||||||||||||||||||||
BENZODIAZEPINES
Drug
class: DEA
Classification: Retention (Detection) Times: |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| * Not a benzodiazepine - A false positive (Can be ruled
out by TLC) |
||||||||||||||||||||||||||||||||||||||||||||||||||
NOTES
:
|
||||||||||||||||||||||||||||||||||||||||||||||||||
COCAINE
(BENZOYLECGONINE)
Drug
class: DEA Classification: Retention (Detection) Times: |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| * Benzoylecgonine is a specific primary metabolite of
cocaine. It is stable in urine and is therefore used for
the specific detection of cocaine. Parent cocaine can
be detected in urine however it is unstable and is rapidly
converted to benzoylecgonine. |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
MARIJUANA
(THC)
Drug
class: DEA
Classification: Retention (Detection) Times: Elimination
Half-Life: Analytical
Note: Interpretation
of Results : |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Interpretation of THC Semi quantitative Values: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Semi-quantitative THC values are of little use when determining
possible renewed marijuana use. A helpful method of answering
this question is to normalize the cannabinoid concentration
to the urine creatinine value of the sample. Random urine
specimens contain varying amounts of creatinine depending
on the concentration of the urine. This THC/creatinine
ratio provides a means to eliminate the urine dilution
problem when interpreting THC values. Therefore, in general,
an increase of >50% in the THC/creatinine ratio above
the previous sample is considered to indicate a new episode
of drug exposure. |
||||||||||||||||||||||||||||||||||||||||||||||||||
METHADONE
/ METHADONE METABOLITE
Drug
class: DEA Classification: Retention (Detection) Times: |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| * The EIA method for methadone will detect LAAM at high
concentrations. LAAM is quickly metabolized therefore
parent LAAM will not always be detected. |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Interpretation of Results: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
OPIATES
Drug
class: DEA Classification: Retention (Detection) Times: |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| * These drugs may not test positive at therapeutic levels. ** Thin-Layer chromatography (TLC) confirmation will specifically identify which opiate was detected. *** Notice that hydrocodone, hydromorphone, and oxycodone require higher levels to be present in urine than codeine or morphine to screen positive. |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
NOTES :
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Forensic
Laboratories is certified and licensed by the Department
of Health & Human Services Health Care Financing Administration
(CLIA ¡¯88, CLIA ID# 06D0982654). |
||||||||||||||||||||||||||||||||||||||||||||||||||
THC
INTERPRETATION
The values
that Forensic Laboratories report for THC are only to
be interpreted as an estimation of the quantitative weight
per volume measurement. Urinary THC values are very difficult
to interpret due to variables such as frequency of marijuana
use, amount used, urine concentration, body weight, etc.
Therefore, positive urine specimens for THC merely indicate
that marijuana was ingested at some time in the past.
Based upon our experience using these values, the urine
content of THC can be interpreted as follows: |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| NOTES : Interpretation of retention time must take into account several variables such as drug metabolism, half-life, patient's physical condition, fluid intake, method and frequency of ingestion, drug dosage, etc. These are general guidelines only. For questions, please call Forensic Laboratories at (303) 469-8042. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Urine Creatinine Interpretation THC/Creatinine Normalization | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Introduction | ||||||||||||||||||||||||||||||||||||||||||||||||||
| THC is
one of the numerous cannabinoid chemicals present in marijuana
as well as the primary psychoactive ingredient. Cannabinoid
metabolites appear in urine within two to four hours after
smoking marijuana and may persist up to 30 days (at the
50 ng/mL cutoff concentration) depending upon a person's
previous pattern of abuse. In general, infrequent use
of marijuana may only be detected for 1-3 days after use.
Regular use, several times per week, may be detected for
7-10 days, while chronic use of marijuana may be detectable
for up to 30 days. Routine passive inhalation to marijuana
will not cause a positive urine drug test for THC at either
a 50 ng/ml or 20 ng/mL cutoff concentrations. The measurement of creatinine concentrations is an important variable to monitor when attempting to determine if an individual has abstained from marijuana between successive urine specimens. The concentration of the THC metabolite, carboxy-THC, can fluctuate from day-today depending upon a persons fluid intake. Increased fluid intake will lower both the carboxy-THC and creatinine concentration in a urine specimen while dehydration will have the opposite effect. Calculation of the carboxy-THC to creatinine normalization neutralizes any change in the carboxy-THC concentration due to variation in a person's hydration state. This calculation makes it possible to compare urine specimens to establish if renewed use of marijuana has occurred. |
||||||||||||||||||||||||||||||||||||||||||||||||||
Semi-quantitative EIA Results The enzyme
immunoassay (EIA) values reported by Forensic Laboratories
for THC (marijuana) are only to be interpreted as an estimation
of the concentration of total cannabinoids (marijuana
metabolites) present in a urine specimen. Urinary cannabinoid
values are difficult to interpret due to variables such
as frequency of use, duration of use, amount used, and
an individual's liquid consumption. Therefore, positive
EIA results for THC (cannabinoids) indicate use of marijuana
but numerous additional considerations, such as THC/Creatinine
normalization are required to establish renewed or continued
use. |
||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Urine Creatinine Interpretation THC/Creatinine Normalization (Con't) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| The
use of the EIA values provides preliminary clinical information
for single use of marijuana. Because the analysis of a
single urine specimen cannot typically distinguish between
very recent use and chronic use, the exact time of use
cannot be determined with any certainty. A more reliable determination of renewed use
of marijuana requires the comparison of the THC/Creatinine
normalization between multiple urine specimens. This normalization
can be calculated by dividing the THC± value by the Creatinine
value then multiplying by 100. In general, an increase
of more than 50% in the THC/Creatinine normalization between
two urine specimens provides clinical evidence of possible
renewed use. If the THC/Creatinine results are to be used
for punitive or administrative purposes, GC/MS
confirmation analysis must be performed to provide a definitive
interpretation of renewed marijuana use. The following graph is actual data from a client with a chronic history of smoking marijuana who was being routinely monitored for drug use: |
||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||
| The
top curve represents the THC (cannabinoid) values based
upon the EIA analysis while the bottom curve is a plot
of the respective "THC/Creatinine" Normalization.
Although the graph shows an increase in the THC value
from 180 to 258 between days 14 and 17, respectively,
the corresponding normalization actually decreased from
102 to 82. Thus, although the THC values might have caused
concern of renewed marijuana use, the THC/creatinine normalization
actually decreased. This decrease in the normalization
is more indicative of continued elimination of marijuana. |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Urine Creatinine Interpretation THC/Creatinine Normalization (Con't) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| A plot of the THC and THC/creatinine normalization from another subject yields a different interpretation: | ||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||
| The data
revealed decreasing "THC" values of 200 and
150 for days 12 and 14, respectively. In contrast, the
corresponding THC/Creatinine normalization show a sharp
increase from 75 to 536, respectively. Although the THC
values do not suggest renewed use between the two urine
specimens, the normalized values provide strong clinical
evidence of renewed use. For conclusive evidence, only
these two urine specimens need to be confirmed by GC/MS
analyses. If the increase in the normalization is further
substantiated with GC/MS analyses, then it can be concluded,
with scientific certainty, that the individual had used
marijuana between the two urine collections.
Finally, although an initial EIA positive test in combination with an EIA semi-quantitative positive result provides preliminary interpretation information; clinical consideration and professional judgment should be considered for more reliable interpretation. Forensic Laboratories strongly recommends consulting with a toxicologist and gas chromatography/mass spectrometry (GC/MS) confirmation prior to any administrative or legal action. |
||||||||||||||||||||||||||||||||||||||||||||||||||
800-282-6574 • Email Forensic Laboratories • 4895 Joliet Street • Denver, Colorado 80239
Copyright © 2009 Forensic Laboratories. All rights reserved. Site by Brand Iron, a branding agency.

